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Human Natural Killer-1 (HNK-1) carbohydrate, comprising a unique trisaccharide 
HSO3-3GlcAβ1-3Galβ1-4GlcNAc, shows well-regulated expression and unique functions in the nervous 
system. Recent studies have revealed sophisticated and complicated expression mechanisms for HNK-1 
glycan. Activities of biosynthetic enzymes are controlled through the formation of enzyme-complexes 
and regulation of subcellular localization. Functional aspects of HNK-1 carbohydrate were examined by 
overexpression, knockdown and knockout studies of these enzymes. HNK-1 is involved in several neural 
functions such as synaptic plasticity, learning and memory, and the underlying molecular mechanisms 
have been illustrated upon identification of the target carrier glycoproteins of HNK-1 such as the 
glutamate receptor subunit GluA2 or tenascin-R. In this review, we describe recent findings about HNK-1 
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Introduction 
The expression and cellular functions of proteins are regulated by post-translational modifications such as 
phosphorylation, proteolytic cleavage, ubiquitination, and acetylation. Glycosylation is the most frequent 
protein modification in mammals, with over half of proteins estimated to be glycosylated [1]. Glycans 
expressed on proteins have enormous structural diversity and play pivotal roles in many physiological 
processes at molecular, cellular and individual levels [2]. Also, a specific glycan and the enzyme 
producing it are expressed in a cell type-dependent manner, which is closely related to a specific function 
such as sialyl 6-sulfo lewisX in lymph node and a specific N-glycan branch in pancreatic beta-cells [3,4]. 
Cell-specific glycans are also used as cell markers, such as SSEAs for stem cells [5]. In the nervous 
system, unique glycans such as polysialic acids are involved in many neural functions, and the impaired 
functioning of neural specific glycans causes neural disorders like schizophrenia, hydrocephalous and 
neuropathy [6-9]. 
     Human Natural Killer-1 (HNK-1) is one such neural glycan epitope that is predominantly 
expressed in brain and peripheral nervous tissues. HNK-1 is composed of a sulfated trisaccharide, 
HSO3-3GlcAβ1-3Galβ1-4GlcNAc- [10], found at the non-reducing terminus of glycans (Fig. 1A). This 
glycan epitope is biosynthesized in the Golgi apparatus the same as many other glycosylation reactions. A 
terminal sulfated glucuronic acid is quite rare among glycans. Usually the glycan terminus is capped with 
another acidic monosaccharide, sialic acid, in mammals [11,12]. HNK-1 epitope is mainly expressed in 
N-glycan and in O-mannose glycan [13-15], and is not found in other types of O-glycan under 
physiological conditions. In addition, HNK-1 glycan has some structural varieties such as non-sulfated 
form or 6-sulfation of the inner GlcNAc residue [16,17]. During the last few decades, we and others have 
reported that this structurally unique glycan plays physiologically important functions in the nervous 
system revealed by using specific antibody, gene-knockout and knockdown studies. Also, the 
identification and cDNA cloning of key biosynthetic enzymes for HNK-1 glycan have been elucidating 
well-controlled expression mechanisms for this unique glycan. Here, we focus on how HNK-1 glycan is 
expressed and exerts its functions in the nervous system, and also discuss newly emerging issues. 
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Characteristic expression of HNK-1 glycan in the nervous system 
HNK-1 was first identified as an antigen at the surface of human natural killer cells in 1981 [18], and a 
HNK-1 monoclonal antibody was widely used in subsequent studies. The epitope of the HNK-1 antibody 
was also designated as CD57 and is still used as a marker for some T-cell populations in immunology 
[19]. However, later studies revealed that HNK-1 antigen is highly expressed in the nervous system 
including in chick embryonic neural crest cells [20] and mammalian brain [21], while not detected in 
other tissues. Now, with the identification of neural specific biosynthetic enzymes, HNK-1 epitope is 
considered to be predominantly expressed in the nervous system.  
     In the central nervous system, HNK-1 is widely distributed over most of mouse brain [22], with 
some characteristic expression patterns such as parasagittal stripes in cerebellum [23]. In the peripheral 
nervous system, HNK-1 was found in myelinating Schwann cells that are associated with motor axon but 
not in cells that are associated with sensory axon [24], suggesting that HNK-1 carbohydrate may be 
specifically involved in axon outgrowth/regrowth of motor neurons. Of note, expression of HNK-1 in 
Schawann cells seems to vary between human and rodents [25]. These previous studies as well as recent 
studies often used specific antibodies, and some kinds of monoclonal antibodies commonly recognize the 
HNK-1 epitope with slight different binding specificities. For example, 412 mAb and M6749 mAb can 
detect both sulfated and non-sulfated form of HNK-1 carbohydrate [16,26].  
     Interestingly, HNK-1 glycan is only carried by certain kinds of molecules, indicating that this 
glycan is biosynthesized in the Golgi in a tightly regulated manner. HNK-1-carrying molecules identified 
in the nervous system to date include Ig-superfamily adhesion molecules (NCAM, L1, P0, MAG etc 
[21,27]), a specific glutamate receptor subunit (GluA2) [28], a GPI-anchored protein (CD24) [29], 
soluble extracellular proteins (tenascin-R, tenascin-C and phosphacan [30-32]), and glycolipids [10]. The 
fact that even a highly homologous glycoprotein like GluA1 forming a complex with GluA2 is not 
modified with HNK-1 in vivo suggests that the expression mechanism of HNK-1 is elaborate. Previously, 
we compared specific activities of the biosynthetic glucuronyltransferase toward certain glycoprotein 
acceptors. Surprisingly, however, the enzyme similarly transferred glucuronic acid to both a natural 
acceptor protein (NCAM or L1) and a non-natural acceptor (asialo-orosomucoid), suggesting that the 
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HNK-1-synthesizing enzyme does not recognize their polypeptide sequence at least in vitro [33]. Thus we 
now speculate that HNK-1-carrying molecules are somehow directed to a specific route for HNK-1 
modification in the Golgi apparatus in living cells, but the molecular mechanism by which HNK-1 
modification occurs on specific molecules in vivo has yet to be elucidated. 
 
Biosynthetic enzymes of HNK-1 glycan 
The most unique structural feature of the HNK-1 epitope is a β3-linked glucuronic acid attached to the 
non-reducing end of a galactose residue (Fig. 1A). Our group had set out to biochemically identify the 
glucuronyltransferase responsible. Sequential column chromatography procedures successfully isolated 
one glucuronyltransferase from rat brain that we named GlcAT-P (B3GAT1 gene) [34,35]. This enzyme 
completely satisfied the biochemical requirements for a HNK-1-synthesizing enzyme such as 
predominant mRNA expression in the brain, a type-II membrane topology typical of a glycosyltransferase, 
and a mildly acidic optimal pH suitable for reactions in the Golgi. The transfection of GlcAT-P actually 
elicited ectopic expression in HNK-1 antigen in non neural cells like COS-1 cells [34]. Also, a GlcAT-P 
gene-knockout study clearly showed that it is the major enzyme responsible for HNK-1 synthesis in the 
brain as described below. After that, we and another group independently cloned a homologous 
glucuronyltransferase designated as GlcAT-S (or GlcAT-D) (B3GAT2) from a rat brain cDNA library 
that also showed HNK-1-synthesizing activity [36,37]. Although GlcAT-P and –S showed similar activity 
when overexpressed in cultured cells [38], they differed in their expression patterns, substrate glycan 
specificity and physiological functions. 
     Another homologous β1,3-glucuronyltransferase was also identified, GlcAT-I (B3GAT3) [39]. 
GlcAT-I is involved in the synthesis of a linkage tetrasaccharide of glycosaminoglycan (Fig. 1B), 
GlcAβ1-3Galβ1-3Galβ1-4Xyl-Ser, which is commonly found in chondroitin or heparan sulfate [40]. 
GlcAT-I also displayed HNK-1-synthesizing activity only when overexpressed in cultured cells [40,41], 
but its ubiquitous expression, biochemical analysis and knockout experiments all showed that the main 
physiological function of this enzyme is to biosynthesize the linkage structure for glycosaminoglycan 
[42]. 
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     The other structural determinant of HNK-1 is the terminal sulfate group. We and Dr. Fukuda’s 
group independently identified the same sulfotransferase involved in this sulfation reaction, which is now 
called HNK-1ST (CHST10) [43,44]. Although other sulfotransferases such as chondroitin 
sulfotransferases show amino acid sequence similarity to this enzyme, biochemical properties and 
knockout experiments suggested that HNK-1ST is the sole sulfotransferase for HNK-1 synthesis in vivo 
[45]. Interestingly, however, HNK-1ST is expressed in non-neural tissues where GlcAT-P and S are not 
expressed [44]. In addition, HNK-1ST can form enzyme complex with GlcAT-I despite no apparent 
usefulness for HNK-1 synthesis [38]. These results suggest that this sulfotransferase has additional 
functions other than in HNK-1 biosynthesis. Actually, we and Dr. Sugahara’s group demonstrated that 
HNK-1ST can use a glycosaminoglycan linkage tetrasaccharide on thrombomodulin as an acceptor 
substrate to form an unusual sulfated structure (Fig. 1B) [46,47]. The sulfated linkage region on 
thrombomodulin was indeed identified in human urine, SO4-3GlcAβ1-3Galβ1-3Galβ1-4Xyl [48], and a 
non-elongated form of proteoglycan is known to exist as a part-time proteoglycan [49,50]. The sulfated 
linkage region of thrombomodulin can no longer be used for the further elongation of chondroitin sulfate 
[46], indicating that the action of HNK-1ST may be an off-switch for glycosaminoglycan biosynthesis. It 
is an intriguing question whether this unusual sulfated linkage region is also expressed in other 
proteoglycan molecules or in brain under physiological conditions.  
 
  Substrate specificity of GlcAT-P and GlcAT-S 
The enzymatic properties of GlcAT-P and S have been characterized using recombinant enzymes [33,51]. 
Both enzymes efficiently transfer glucuronic acid from UDP-GlcA to the non-reducing terminus of the 
acceptor glycan of glycoprotein, glycolipid and oligosaccharide substrates. However, they differ in 
features like acceptor specificity. Our detailed enzymatic characterization revealed that while GlcAT-P 
strictly recognizes the N-acetyllactosamine structure (Galβ1-4GlcNAc) as an acceptor which is the 
known inner structure of HNK-1 glycan, GlcAT-S can efficiently transfer GlcA to a lacto-N-biose 
structure (Galβ1-3GlcNAc) as well as N-acetyllactosamine. In addition, GlcAT-P exhibited almost 
equally efficient activity toward bi-, tri- and tetra-antennary N-glycans [52], while GlcAT-S preferred 
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tri-antennary N-glycan [51]. The presence of a bisecting GlcNAc or core α1,6-fucose in N-glycan had 
little effect on the activities of GlcAT-P(S), indicating that the glycan structure of the non-reducing 
terminus is the factor most critical to the specificity of GlcAT-P and S. Notably, the activities of these 
glucuronyltransferases are regulated differently by phospholipids. For example, sphingomyelin increased 
GlcAT-P activity toward the glycoprotein acceptor by five-fold but had no effect on GlcAT-S activity 
[51]. These results suggest the activities of these enzymes to be regulated by the surrounding 
microenvironment in the Golgi apparatus. 
 	  
  Crystal structure and catalytic reaction of GlcAT-P and -S 
To elucidate the reaction mechanisms of GlcAT-P and S in more detail, the crystral structures of these 
two enzymes were solved [53,54]. Recombinant catalytic domains of human GlcAT-P and -S were 
expressed in and purified from E. coli, and these soluble enzymes showed levels of activity in vitro 
comparable to those of the native enzymes [53]. Crystallographic studies revealed that the two enzymes 
had a similar overall structure including GT-A type folding with a Rossman-like fold, a tight 
homodimeric form, and a conserved DXD motif commonly found in UDP-sugar-utilizing 
glycosyltransferases [55]. Binding sites for the donor substrate (UDP-GlcA) were almost completely 
conserved between GlcAT-P and –S, but the two differed in how they recognized acceptor substrates. 
Key residues of GlcAT-P for binding to Galβ1-4GlcNAc are Phe245 and Val320 which form parallel 
stacking interaction and hydrophobic interaction with the GlcNAc moiety, respectively. Computer-aided 
modeling of the docking of Galβ1-3GlcNAc (poor substrate) with GlcAT-P showed that Phe245 may 
form poorer stacking interaction, and Val320 no longer interacts with GlcNAc, which is consistent with 
the strict acceptor specificity of GlcAT-P toward Galβ1-4GlcNAc. In the case of GlcAT-S, Phe245 and 
Val320 of GlcAT-P correspond to Trp234 and Ala309, which probably allows GlcAT-S to recognize 
Galβ1-3GlcNAc as well as Galβ1-4GlcNAc. Consistent with this, a mutant GlcAT-S in which Trp234 
and Ala309 were replaced by Phe and Val, respectively, showed a drastic reduction in activity toward 
Galβ1-3GlcNAc, resembling GlcAT-P, which supports our observation that these residues are critical for 
acceptor recognition. From a structural point of view, a catalytic mechanism was also proposed in which 
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an acidic residue (Glu284 for GlcAT-P and Glu273 for GlcAT-S) served as a catalytic base to 
deprotonate the 3-position of Gal and then the nucleophilic deprotonated Gal attacks the C1 carbon of 
GlcA in UDP-GlcA to create GlcAβ1-3Gal. 
     Interestingly, both GlcAT-P and S have a disordered mobile loop region which shows no electron 
density. Most glycosyltransferases have such a region, called a flexible loop, considered to be involved in 
substrate binding [56]. In the case of β4GalT1, where the flexible loop can be traced even without 
substrates, conformational change from an opened to closed form occurs upon binding with UDP-Gal. 
After the binding to UDP-Gal, the flexible loop moves and acts as a lid to cover the binding pocket. In the 
case of GnT-I, the loop was disordered in the apo-form, but structured in the donor-bound form [57]. In 
GlcAT-P, the loop was still invisible even in a co-crystal with a donor-substrate. Deletion of the entire 
loop (7 amino acids) or a point mutation of two acidic amino acids in the GlcAT-P loop almost 
completely abrogated the activity in cells [58]. Although the loop obviously plays a pivotal role in 
GlcAT-P activity, a more detailed analysis is needed to uncover its function. 
 
Regulation of HNK-1 expression in cells 
 	 Gene regulation of biosynthetic enzymes 
As described above, HNK-1 glycan is predominantly expressed in the nervous system. Consistent with 
this, GlcAT-P and S showed tightly regulated expression patterns with high levels in brain tissue [34,36]. 
Studies have partially revealed the transcriptional control mechanisms for these glucuronyltransferase 
genes. Our analysis suggested the cis-element in the GlcAT-P promoter including the binding site for Sp1 
and Krox20 to be required for neural expression of the mouse GlcAT-P gene [59]. An in vivo study 
showed that in Pax6 mutant rats, HNK-1 and GlcAT-P gene expression is ectopically upregulated, 
suggesting that Pax6 is a negative regulator for the GlcAT-P gene in rat embryonic brain [60]. Another 
report demonstrated that TNFα signaling up-regulates GlcAT-P(S) gene expression in brain endothelial 
cells, which supports a role for HNK-1 in inflammatory responses through interaction between HNK-1 
and selectin [61]. More recently, we found the brain-specific expression of the mouse GlcAT-P gene to be 
highly correlated with epigenetic histone activation marks, indicating that the GlcAT-P gene is 
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epigenetically regulated [62].  
     One interesting finding is that the GlcAT-S gene is highly expressed in mouse kidney as well as 
brain [16], while GlcAT-P and HNK-1ST are not expressed in mouse kidney, suggesting a specific role 
for GlcAT-S in kidney even without the sulfotransferase action. Actually, expression of a non-sulfated 
form of HNK-1 (GlcAβ1-3Galβ1-4GlcNAc) in mouse kidney was confirmed by a specific antibody and 
tandem mass-spectrometry, and we identified three major glycoproteins carrying this glycan (CD13, 
meprin-α and laminin-111) [16,63]. CD13 and meprin are metalloproteases highly expressed in kidney 
brush border membrane [64,65], and laminin-111 is a well-characterized component of basement 
membranes that serves as a ligand for integrin or dystroglycan [66]. Another group reported that GlcA in 
the N-glycan of a calcium channel, TRPV5, in kidney is required for its retention at the cell surface and 
for calcium homeostasis [67], but we have not detected the expression of a non-sulfated HNK-1 on 
TRPV5 in mouse kidney (unpublished results). In addition, HNK-1 expression in kidney seems to differ 
among species. In mouse, we found non-sulfated HNK-1 was expressed on apical membranes of proximal 
tubules and thin ascending limb in medulla, but in other species sulfated HNK-1 is expressed in thin 
ascending loop of Henle and may be carried by proteoglycan molecules [68]. So far, it is still unclear how 
the non-sulfated HNK-1 regulates the functions of these glycoproteins. We have generated GlcAT-S 
deficient mice and confirmed the disappearance of the non-sulfated HNK-1 in kidney (unpublished 
results), and are currently investigating the role of GlcAT-S in kidney as well as in brain. 
     Regarding HNK-1ST, there has been almost no promoter analysis. But one intriguing report 
showed that the HNK-1ST gene is a target for a transcription factor, retinoic acid receptor-gamma, and 
upregulation of this gene through this pathway in melanoma cells is functionally involved in suppression 
of invasiveness (as described below) [69]. HNK-1ST gene transcription must be regulated in a different 
manner from GlcAT-P(S), and an analysis of its gene regulation mechanism would be an interesting 
future study. 
 
 	 Functional enzyme complex for HNK-1 synthesis 
Another regulatory mechanism for HNK-1 expression is that intracellular activities of biosynthetic 
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enzymes are controlled by the formation of a protein complex or fine subcellular localization in living 
cells. The idea that GlcAT-P(S) might interact with HNK-1ST first came from the fact that almost all the 
HNK-1 structures identified so far are sulfated. Thus we hypothesized that HNK-1ST associated with 
GlcAT-P(S) to efficiently transfer a sulfate group to GlcA. This idea also suggests the functional 
importance of the sulfate moiety in HNK-1. Actually, using co-immunoprecipitation experiments we 
found that GlcAT-P(S) and HNK-1ST physically interact in living cells when they are transiently 
expressed (Fig. 2A) [38]. This interaction is highly specific because we did not detect the binding using 
either a sialyltransferase instead of GlcA-P(S) or other sulfotransferases instead of HNK-1ST. 
Functionally, we revealed that the specific activity of HNK-1ST is upregulated by interaction with 
GlcAT-P(S), whereas the activity of GlcAT-P(S) is not influenced by HNK-1ST [38]. This result is 
consistent with our assumption that the enzyme complex enables efficient sulfation as soon as 
glucuronylation occurs during HNK-1 synthesis. 
     We also focused on the biosynthesis of the inner N-acetyllactosamine structure (Galβ1-4GlcNAc). 
This carbohydrate structure is used for a wide variety of glycans and is synthesized by a 
β1,4-galactosyltransferase (β4GalT). The β4GalT family is composed of seven isozymes (β4GalT1 to 
β4GalT7), some of which are involved in the synthesis of Galβ1-4GlcNAc in N-glycan [70,71]. Although 
it had been unknown which β4GalT is responsible for synthesis of the inner Galβ1-4GlcNAc of HNK-1 
glycan, we found that HNK-1 expression almost completely disappeared in β4GalT2 deficient mouse 
brain [72]. In contrast, knockout of β4GalT1, a major and ubiquitous β4GalT, did not affect HNK-1 
expression at all [13,73]. These results strongly indicated that β4GalT2 is a key enzyme for HNK-1 
synthesis and led us to hypothesize that β4GalT2 forms a specific complex with GlcAT-P(S) (and 
HNK-1ST). When co-expressed with GlcAT-P, β4GalT2 but not β4GalT1 can be co-immunoprecipitated 
with GlcAT-P [13]. In addition, expression of an ER-retained mutant of GlcAT-P redistributed β4GalT2 
but not β4GalT1 from the Golgi to the ER, again indicating that β4GalT2 specifically associates with 
GlcAT-P in cells. Functionally, addition of β4GalT2 upregulated the specific activity of GlcAT-P in vitro, 
and co-expression of β4GalT2 and GlcAT-P enchanced HNK-1 expression in cells compared to that of 
only GlcAT-P. All these results support that β4GalT2 plays a key role in HNK-1 synthesis by forming a 
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complex with GlcAT-P. 
     These studies imply that a specific enzyme complex composed of β4GalT2, GlcAT-P(S) and 
HNK-1ST is present and that this specialized machinery may be placed in a defined compartment in the 
Golgi (Fig. 2A). Only specific acceptor molecules can pass by this compartment to become modified with 
HNK-1 glycan. Dr. Goto’s group proposed that in drosophila, functionally related molecules form a 
distinct functional unit in Golgi, called the Golgi unit [74]. The mammalian glycosylation machinery 
might be similarly organized with different functional units. Unfortunately, however, endogenous levels 
of HNK-1-synthesizing enzymes are quite low under physiological conditions. This is also the case for 
many glycosyltransferases. Investigation of the endogenous molecular features of glycosyltransferases 
and their complexes in the Golgi would be a difficult but fascinating challenge. 
 
 	 Regulated subcellular localization of GlcAT-P 
The intracellular activity of GlcAT-P is also regulated by controlling its subcellular localization. We 
found that isoforms of GlcAT-P generated by alternative splicing showed distinct localization patterns 
which are well-correlated with their intracellular activities [75]. These isoforms had previously been 
identified in mice and humans [59,76], differing in only the presence or absence of 13 N-terminal amino 
acids (Fig 2B). The expression of these two isoforms (short GlcAT-P, sGlcAT-P and long GlcAT-P, 
lGlcAT-P) resulted in a clearly different expression of the HNK-1 epitope in cells, and sGlcAT-P 
exhibited quite high intracellular activity despite having the same catalytic domain and similar specific 
activity in vitro [75]. More detailed analysis clarified that sGlcAT-P is localized to the Golgi but 
lGlcAT-P resides in both the Golgi and the ER. ER-distributed lGlcAT-P is assumed not to act as an 
enzyme because of a lack of the acceptor Galβ1-4GlcNAc in the ER, which accounts for the weak 
intracellular activity of lGlcAT-P. ER-exit of some glycosyltransferases is dependent on binding with 
COP-II vesicle component Sar1 that directly recognizes a dibasic motif [K/R](X)[K/R] of the cytosolic 
tail of glycosyltransferases [77]. GlcAT-P also has this motif in its N-terminal tail and is actually bound 
by Sar1, but lGlcAT-P showed weaker binding with Sar1 than sGlcAT-P presumably because of the close 
existence of the 13 additional amino acids (Fig. 2C) [75].  
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     Although we still do not know how these strong and weak GlcAT-Ps are used in nature, both 
isoforms are indeed expressed in brain. β4GalT1 has two similar isoforms with or without an additional 
13 amino acids in the cytoplasmic tail, which are distributed differently in cells and regulated 
differentially at the transcriptional level. In somatic cells the longer mRNA variant is dominant, while in 
mammary gland the shorter variant is upregulated [78]. It would be interesting to examine how 
transcription of the two GlcAT-P mRNAs is regulated in specific brain regions, neural cell types, and 
developmental periods.  
 
In vivo HNK-1 Function 
 	 Role of HNK-1 during development 
HNK-1 had received attention from developmental biologists because of its characteristic expression in 
chick neural crest cells [20] which show a highly dynamic migration during development [79]. 
Application of an HNK-1 antibody perturbed the migration of cranial neural crest cells in the chick 
embryo, indicating that HNK-1 glycan is functionally involved in neural cell migration [80]. Although 
the expression of HNK-1 in rodent neural crest cells is still enigmatic [81], overexpression of GlcAT-P in 
rat neural crest cells also affected the migratory distance and pattern [82], suggesting the importance of 
HNK-1 in cell migration during neural development. 
     Another HNK-1 function was reported in neural stem cells [32]. HNK-1 glycan was expressed in 
undifferentiated mouse neural stem cells and down-regulated upon differentiation. The carrier 
glycoprotein for HNK-1 was identified as tenascin-C, and only the largest isoform seemed to be modified 
with HNK-1. By depleting HNK-1 expression in neural stem cells using siRNA for HNK-1ST, it was 
demonstrated that HNK-1 on tenascin-C is functionally involved in the proliferation of neural stem cells 
via modulation of EGF receptor expression. 
     To examine the role of HNK-1 during development at the individual level in vertebrates, we 
performed knockdown and overexpression of GlcAT-P (S) in medaka fish, a well established model for 
developmental studies [83]. In medaka, HNK-1 expression is weak at the gastrulation stage and gradually 
increases in neural tissues during development. We first cloned cDNAs of GlcAT-P and S that are 
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conserved also in medaka. Overexpression of each glucuronyltransferase affected embryogenesis along 
with ectopic overexpression of HNK-1 glycan. In particular, abnormal curvature in the head region was 
observed with a severer phenotype on the overexpression of GlcAT-S than of GlcAT-P. In knockdown 
experiments using morpholino-oligonucleotides, depletion of GlcAT-P caused severe abnormalities in 
head formation, while knockdown of GlcAT-S resulted in no obvious phenotype, suggesting that these 
two glucuronyltransferases have different functions in vivo. These results indicate that GlcAT-P is 
essential for medaka development especially for the formation of the head region and that well-controlled 
expression of HNK-1 is required for proper embryogenesis in fish development. 
 
 	 Phenotypes of enzyme gene-deficient mice 
We generated GlcAT-P gene-deficient mice to examine the physiological roles of HNK-1 in mammals 
[84]. HNK-1 expression in the knockout mouse brain almost disappeared except in specific regions such 
as the perineuronal net (described below), indicating that GlcAT-P is the major glucuronyltransferase in 
mouse brain. Despite the marked loss of HNK-1 expression in the mutant mice, normal birth and overall 
brain morphology were observed. However, electrophysiological analysis and behavioral tests revealed 
that these knockout mice showed abnormal brain functions such as impairment of synaptic plasticity and 
spatial learning. Frequent stimulation of afferent fibers in the hippocampus evoked long lasting changes 
in synaptic strength (synaptic plasticity) called LTP (long term potentiation) that is considered to underlie 
memory function [85]. The magnitude of LTP in the hippocampal CA1 region was significantly reduced 
in GlcAT-P-deficient mice, suggesting that HNK-1 glycan is required for synaptic plasticity and memory 
formation [84]. In addition, in the Morris water maze test and water-filled multiple T-maze test, 
GlcAT-P-deficient mice showed reduced spatial learning and memory, which is consistent with impaired 
synaptic plasticity [84]. Knockout of the HNK-1ST gene also caused a reduction of LTP in the 
hippocampus and poor performance in the water maze tests [45]. In addition, β4GalT2-deficient mice, 
which showed a marked reduction of HNK-1 expression as described above, also exhibited impaired 
performance in the water maze test [72]. All these results support that HNK-1 glycan is required for 
learning and memory formation. β4GalT2 knockout mice also showed retarded motor learning as 
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assessed by the rota-rod test [72], while GlcAT-P knockout mice performed normally suggesting that this 
phenotype is caused by a loss of intrinsic β4GalT2 function other than the loss of HNK-1 expression. 
 
Mechanism underlying reduced synaptic plasticity caused by the loss of HNK-1 expression 
 	 HNK-1 stabilizes GluA2 on the neuronal cell surface 
To examine the molecular mechanism underlying the reduced synaptic plasticity and memory formation 
in GlcAT-P-deficient mice, we set out to identify the molecule responsible. We found a specific 
glycoprotein carrying HNK-1 to be highly concentrated in the hippocampal postsynaptic density fraction 
(PSD). This glycoprotein was immunoaffinity-purified and identified as a subunit of AMPA-type 
glutamate receptors, GluA2 [28]. AMPA-type glutamate receptors mediate most of the fast excitatory 
synaptic transmission in the mammalian brain and control synaptic strength. The regulated trafficking of 
AMPA receptors to the postsynaptic membrane is thought to be a major mechanism contributing to 
long-lasting changes in synaptic strength including LTP [86]. In mature pyramidal neurons, GluA1 and 
GluA2 are predominantly expressed, and the great majority of AMPA receptors contain GluA2 subunits. 
GluA2 subunits have important roles in the assembly and trafficking of AMPA-type glutamate receptors, 
and recent studies also indicated that the redistribution of GluA2 from the intracellular compartment to 
synaptic membrane underlies the mechanism of synaptic plasticity [86]. Thus, we hypothesized that 
impaired trafficking of GluA2 may be a molecular mechanism of reduced LTP in GlcAT-P-deficient mice. 
Actually, GluA2 was more prone to be internalized in GlcAT-P knockout hippocampal neurons than 
wild-type neurons under basal and stimulated conditions, though expression of the GluA2 protein itself 
was normal in the knockout neurons [28]. Moreover, we found that the interaction of GluA2 with 
N-cadherin was impaired in GlcAT-P knockout neurons, conversely, the interaction was enhanced by the 
overexpression of HNK-1 in cultured cells [28]. Since it was reported that GluA2-N-cadherin interaction 
is required for neuronal surface expression of GluA2 and its spine-promoting activity [87], our results 
suggest that HNK-1 glycan stabilizes GluA2 on the synaptic membrane through enhancement of the 
interaction with N-cadherin (Fig. 3A). The unstable surface expression of GluA2 in GlcAT-P-deficient 
neurons may be a molecular mechanism of the impaired induction of LTP in GlcAT-P knockout brain.  
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 Requirement of HNK-1 for dendritic spine maturation 
Meanwhile, we examined the morphological features of dendritic spines and synapses in 
GlcAT-P-deficient neuron, because morphological maturation of dendritic spines is highly related to 
synaptic plasticity [88]. Dendritic spines are specialized actin-rich mushroom-like protrusions where an 
input from another neuron (synapse) is received. One explanation of their origin is the maturation of 
filopodium-like immature protrusions [89]. The abundance of AMPA receptors at the postsynapse is 
related to spine size, and it was reported that overexpression of GluA2 resulted in promotion of spine 
morphogenesis due to interaction with N-cadherin. [87]. Given that loss of HNK-1 impairs GluA2’s 
association with N-cadherin and stabilization at the cell surface in GlcAT-P knockout neurons, we 
hypothesized that spine morphogenesis may be impaired in these mutant mice. Expectedly, spines in both 
GlcAT-P knockout mouse hippocampus and cultured neurons showed an immature long and thin 
morphology compared to the mature mushroom-like spines in wild-type mouse hippocampus and neurons 
(Fig. 3B) [90]. In contrast, spine density in the knockout neurons was almost the same as in the wild-type, 
suggesting that the later maturation step in spinogenesis but not early budding step is impaired in 
GlcAT-P knockout neurons. Consistent with the increased number of immature spines in knockout 
neurons, the localization of GluA2 also changed from spines to dendritic shafts (Fig. 3B). Also, the 
promoting effect on spine maturation by GluA2 overexpression was smaller in GlcAT-P knockout 
neurons. All these results strongly suggest that the HNK-1 glycan on GluA2 is required for normal spine 
maturation in developing hippocampal neurons. Although direct evidence that impaired spine maturation 
is the main cause of reduced LTP in GlcAT-P-deficient adult brain is still missing, loss of HNK-1 may 
also contribute to the impaired GluA2 localization under LTP-inducing conditions. 
 
 	 Modulation of perisomatic inhibition through HNK-1 on tenascin-R (TN-R) 
Dr. Schachner’s group extensively studied the role of HNK-1 in perisomatic inhibition. The first evidence 
came from the application of a HNK-1 mAb to hippocampal slices, which reduced perisomatic inhibitory 
postsynaptic currents (pIPSCs), suggesting that HNK-1 glycan regulates perisomatic inhibition in 
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hippocampal pyramidal cells [30]. This effect of the HNK-1 mAb was not observed in TN-R-deficient 
mice but was observed in NCAM-deficient mice, suggesting that HNK-1 on TN-R but not on other 
HNK-1-carrying molecules is responsible for the decreased inhibitory transmission by the mAb. Also, 
similar perisomatic inhibitory currents were actually observed in TN-R-deficient mice. Subsequent study 
using a synthetic HNK-1 carbohydrate or a peptide mimetic for HNK-1 proposed a mechanism 
underlying the reduced inhibitory transmission whereby the HNK-1 carbohydrate directly inhibited 
GABAB receptors by binding to them [91]. In the presence of the HNK-1 mAb, the constitutive inhibition 
of the GABAB receptor by HNK-1 glycan is probably canceled out, leading to elevated extracellular K+ 
concentrations and a reduction in the amount of GABA released. Although reduced perisomatic inhibition 
may be expected to promote LTP in vivo, a reduction of LTP in CA1 was observed in TN-R-deficient and 
HNK-1ST-deficient mice [45,92]. This can be explained by a complicated metaplastic mechanism in 
which reduced inhibitory synaptic activity and elevated excitatory transmission in the CA1 region in 
TN-R knockout brain may lead to an increase in the threshold for LTP induction and impaired LTP [93]. 
More detailed analyses are needed to clarify how GluA2 and TN-R studies are combined and how HNK-1 
glycan regulates the function of each carrier glycoprotein. 
 
 	 HNK-1 in Perineuronal nets 
 	 Although HNK-1 expression is markedly reduced in the GlcAT-P knockout brain, it still occurs in 
some neurons in characteristic regions. HNK-1 immunoreactivity in GlcAT-P knockout mice is mainly 
detected in the perineuronal net (PN), a specialized lattice-like extracellular matrix around a subset of 
neurons (Fig. 4) [22,84]. PNs, comprising TN-R, chondroitin sulfate proteoglycans such as aggrecan and 
phosphacan, and hyaluronan, are formed 2-5 weeks after birth in mice. Although the precise functions of 
PNs have not yet been elucidated, numerous studies support that PNs are involved in synaptic plasticity. 
For example, degradation of PNs by chondroitinase ABC (ChABC) restores the ocular dominance 
plasticity in visual cortex, an experience-dependent plasticity only observed in the juvenile period (called 
critical period), suggesting that the maturation of PNs reduces the potential plasticity of neurons [94]. 
Another example was recently reported about fear memory [95]. Fear memories cannot be erased as 
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easily in adulthood as during the postnatal period. ChABC treatment renders acquired fear memories 
susceptible to erasure even in adults, suggesting that PNs in the adult brain protect fear memories.  
 	 Among the PN components, TN-R, phoshacan and aggrecan are modified with HNK-1. A deficiency 
of TN-R caused morphological alterations of PNs [96], while the knockout of GlcAT-P did not alter PN 
morphology itself [22], suggesting that the altered PN structure in TN-R knockout mice is caused by loss 
of the core protein but not HNK-1 glycan. Phosphacan and aggrecan are suggested to have HNK-1 
glycans on their O-glycans [97], and the major HNK-1-carrying glycoprotein between these two probably 
switches from phosphacan in juveniles to aggrecan in adults along with the maturation of PNs [97]. This 
study was dependent on a monoclonal antibody, Cat-315, whose epitope partially overlapped with 
HNK-1 mAb, though its precise structure has not been clarified. Based on these results, a major 
HNK-1-carrying molecule in GlcAT-P knockout PNs is likely aggrecan. The HNK-1-containing glycan 
structures on these glycoproteins remain to be determined, and the function of HNK-1 on aggrecan in 
mature brain is also unclear. Further study using our knockout mouse brains would be useful to address 
these issues. 
 	  
Involvement in disease 
Although HNK-1 expression is tightly regulated in a nervous system-specific manner, it was reported that 
this glycan is unusually expressed in some cancer cells especially in melanoma cells [98]. An 
immunohistochemical study suggested that the expression of HNK-1 correlated with metastatic potential 
and poor survival [99]. In contrast, another study showed that transcriptional upregulation of the 
HNK-1ST gene via the direct binding of retinoic acid receptor gamma is involved in reduced metastasis 
of murine melanoma cells, suggesting that HNK-1 glycan may suppress metastasis [69]. Recently, Dr. 
Fukuda’s group reported that HNK-1 may act as a tumor suppressor in the case of gliomas through 
attenuation of the ERK pathway [100]. Roles of HNK-1 glycan in cancer cells are still controversial. It 
would be interesting to identify the HNK-1-carrying glycoproteins in melanoma cells to examine in detail 
how this glycan affects their metastatic potential.  
     HNK-1 is also suggested to be involved in other diseases. HNK-1 glycan is highly antigenic and 
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one of the epitopes for auto-antibodies in peripheral demyelinating neuropathy. The epitope for IgM 
M-protein in some paraproteinemia patients was characterized as HNK-1 expressed on MAG and 
glycolipid [101,102]. The injection of an anti-HNK-1/MAG IgM M-protein into cat sciatic nerve or 
sensitization of rabbits and rats with a HNK-1-carrying glycolipid demonstrated the involvement of this 
glycan in demyelination [103,104].  
     It was also proposed that HNK-1 or the enzymes that biosynthesize it may be involved in 
schizophrenia or Alzheimer’s disease (AD). GlcAT-P and S (B3GAT1 and 2, respectively) emerged as a 
candidate for a risk factor for schizophrenia [105,106]. Another study found GlcAT-P to be a target of 
oxidative stress induced by the stimulation of neurons with amyloid-beta, a peptide causative of AD [107]. 
It suggested that the development of AD may lead to oxidation of GlcAT-P, which in turn causes 
downregulation of GlcAT-P activity and HNK-1 expression, leading to impaired memory and learning 
function mediated by the loss of HNK-1 glycan. Although these studies have revealed clinically 
interesting features of HNK-1 glycan, more detailed molecular and cellular experiments should be done 
to clarify how HNK-1 is involved in these diseases. 
     Dr. Schachner’s group developed peptide mimetics of HNK-1 carbohydrate [108,109], and they 
showed their potential for clinical use. The peptides were applied to reconstruction of femoral nerves in 
mice and primates after nerve injury [110,111]. Muscle function recovery was greatly improved after 
glycomimetic application compared to control, supporting their idea that HNK-1 glycan is involved in 




In this review, we focused on HNK-1 glycan in terms of its well-regulated expression, functions in vivo, 
and underlying molecular mechanisms. Although the gene knockout of HNK-1-synthesizing enzymes has 
provided much information about the functions of HNK-1 in the nervous system, the molecular 
mechanisms by which this glycan regulates each carrier and which carrier is really responsible for each 
phenomenon observed in knockout experiments have yet to be elucidated. This is because of a common 
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difficulty in glycobiological studies. That is, one glycosyltransferase is in charge of glycosylation for 
many proteins, and knockout (knockdown) of the enzyme causes loss (downregulation) of glycans on all 
carrier molecules, which makes our interpretation more difficult. Furthermore, even if the glycan 
structures are the same, the glycans on different glycoproteins probably have different functions. Thus, 
we have to investigate and identify a target carrier glycoprotein which mainly contributes to the 
phenomenon observed. In our case, we found a great loss of HNK-1 expression on many glycoproteins in 
the GlcAT-P knockout brain. Thus, we have to seek for a target in the brain (GluA2, TN-R etc) which is 
really involved in synaptic plasticity in vivo.  
     One way of overcoming such a hurdle is to completely clarify the expression mechanism of a given 
glycan. Glycosylation is not a simple process but a multi-regulated event which is controlled by the 
expression level of the enzyme, substrate specificity of the enzyme, sugar-nucleotide level, 
enzyme-complex, subcellular-localization of the enzyme, etc as described above. Also, we propose here 
that specific multi-enzyme complexes may exist in defined Golgi compartments to form specific 
glycosylation machineries. And this may enable a specific glycoprotein to get a specific glycan by 
selectively passing by one of the multi-enzyme complexes. If we know the identity of such glycosylation 
machinery and elucidate the complete mechanism of glycan biosynthesis, we might create a situation in 
cells where only one glycoprotein is not modified with a specific glycan without knocking out the 
biosynthetic enzyme. We believe that examination of the regulatory mechanisms of HNK-1 expression in 
cells will uncover the whole picture of HNK-1 biosynthesis, providing us with further insight into the 
functions of HNK-1 glycan on each carrier glycoprotein. 
 
Acknowledgement 
This work was supported in part by Grant-in-Aid for Scientific Research (B) 21370053 (to S. O.) from 
JSPS and for Scientific Research on Innovative Areas 23110006 (to S.O.) from MEXT, and by the 




[1] Apweiler R, Hermjakob H, Sharon N (1999) On the frequency of protein glycosylation, as 
deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473:4-8 
[2] Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 
126:855-867 
[3] Mitoma J, Bao X, Petryanik B, Schaerli P, Gauguet JM, Yu SY, Kawashima H, Saito H, 
Ohtsubo K, Marth JD, Khoo KH, von Andrian UH, Lowe JB, Fukuda M (2007) Critical 
functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat 
Immunol 8:409-418 
[4] Ohtsubo K, Chen MZ, Olefsky JM, Marth JD (2011) Pathway to diabetes through attenuation of 
pancreatic beta cell glycosylation and glucose transport. Nat Med 17:1067-1075 
[5] Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, 
Pera RR, Behr B, Wu JC, Weissman IL, Drukker M (2011) An antibody against SSEA-5 glycan 
on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 
29:829-834 
[6] Kleene R, Schachner M (2004) Glycans and neural cell interactions. Nat Rev Neurosci 
5:195-208 
[7] Isomura R, Kitajima K, Sato C (2011) Structural and functional impairments of polysialic acid 
by a mutated polysialyltransferase found in schizophrenia. J Biol Chem 286:21535-21545 
[8] Weinhold B, Seidenfaden R, Rockle I, Muhlenhoff M, Schertzinger F, Conzelmann S, Marth JD, 
Gerardy-Schahn R, Hildebrandt H (2005) Genetic ablation of polysialic acid causes severe 
neurodevelopmental defects rescued by deletion of the neural cell adhesion molecule. J Biol 
Chem 280:42971-42977 
[9] Kaida K, Ariga T, Yu RK (2009) Antiganglioside antibodies and their pathophysiological effects 
on Guillain-Barre syndrome and related disorders--a review. Glycobiology 19:676-692 
[10] Chou DK, Ilyas AA, Evans JE, Costello C, Quarles RH, Jungalwala FB (1986) Structure of 
sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some 
IgM paraproteins in neuropathy. J Biol Chem 261:11717-11725 
[11] Brockhausen I, Schachter H, Stanley P (2009) Essentials of Glycobiology, 2nd edition. 
O-GalNAc Glycans.  
[12] Stanley P, Schachter H, Taniguchi N (2009) Essentials of Glycobiology, 2nd edition. N-Glycans.  
21 
[13] Kouno T, Kizuka Y, Nakagawa N, Yoshihara T, Asano M, Oka S (2011) Specific enzyme 
complex of β-1,4-galactosyltransferase-II and glucuronyltransferase-P facilitates biosynthesis of 
N-linked human natural killer-1 (HNK-1) carbohydrate. J Biol Chem 286:31337-31346 
[14] Yuen CT, Chai W, Loveless RW, Lawson AM, Margolis RU, Feizi T (1997) Brain contains 
HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 
2-linked or 2,6-linked hexose (mannose). J Biol Chem 272:8924-8931 
[15] Chai W, Yuen CT, Kogelberg H, Carruthers RA, Margolis RU, Feizi T, Lawson AM (1999) 
High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among 
O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. Eur J Biochem 
263:879-888 
[16] Tagawa H, Kizuka Y, Ikeda T, Itoh S, Kawasaki N, Kurihara H, Onozato ML, Tojo A, Sakai T, 
Kawasaki T, Oka S (2005) A non-sulfated form of the HNK-1 carbohydrate is expressed in 
mouse kidney. J Biol Chem 280:23876-23883 
[17] Gallego RG, Blanco JL, Thijssen-van Zuylen CW, Gotfredsen CH, Voshol H, Duus JO, 
Schachner M, Vliegenthart JF (2001) Epitope diversity of N-glycans from bovine peripheral 
myelin glycoprotein P0 revealed by mass spectrometry and nano probe magic angle spinning 1H 
NMR spectroscopy. J Biol Chem 276:30834-30844 
[18] Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a 
monoclonal antibody (HNK-1). J Immunol 127:1024-1029 
[19] Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57+ T lymphocytes and functional 
immune deficiency. J Leukoc Biol 87:107-116 
[20] Bronner-Fraser M (1986) Analysis of the early stages of trunk neural crest migration in avian 
embryos using monoclonal antibody HNK-1. Dev Biol 115:44-55 
[21] Kruse J, Mailhammer R, Wernecke H, Faissner A, Sommer I, Goridis C, Schachner M (1984) 
Neural cell adhesion molecules and myelin-associated glycoprotein share a common 
carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature 311:153-155 
[22] Inoue M, Kato K, Matsuhashi H, Kizuka Y, Kawasaki T, Oka S (2007) Distributions of 
glucuronyltransferases, GlcAT-P and GlcAT-S, and their target substrate, the HNK-1 
carbohydrate epitope in the adult mouse brain with or without a targeted deletion of the GlcAT-P 
gene. Brain Res 1179:1-15 
[23] Eisenman LM, Hawkes R (1993) Antigenic compartmentation in the mouse cerebellar cortex: 
zebrin and HNK-1 reveal a complex, overlapping molecular topography. J Comp Neurol 
335:586-605 
22 
[24] Martini R, Schachner M, Brushart TM (1994) The L2/HNK-1 carbohydrate is preferentially 
expressed by previously motor axon-associated Schwann cells in reinnervated peripheral nerves. 
J Neurosci 14:7180-7191 
[25] Levi AD, Guenard V, Aebischer P, Bunge RP (1994) The functional characteristics of Schwann 
cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic 
nerve. J Neurosci 14:1309-1319 
[26] Tsvetkov YE, Burg-Roderfeld M, Loers G, Arda A, Sukhova EV, Khatuntseva EA, Grachev AA, 
Chizhov AO, Siebert HC, Schachner M, Jimenez-Barbero J, Nifantiev NE (2012) Synthesis and 
molecular recognition studies of the HNK-1 trisaccharide and related oligosaccharides. The 
specificity of monoclonal anti-HNK-1 antibodies as assessed by surface plasmon resonance and 
STD NMR. J Am Chem Soc 134:426-435 
[27] Burger D, Simon M, Perruisseau G, Steck AJ (1990) The epitope(s) recognized by HNK-1 
antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide 
structures on human P0 and myelin-associated glycoprotein. J Neurochem 54:1569-1575 
[28] Morita I, Kakuda S, Takeuchi Y, Itoh S, Kawasaki N, Kizuka Y, Kawasaki T, Oka S (2009) 
HNK-1 glyco-epitope regulates the stability of the glutamate receptor subunit GluR2 on the 
neuronal cell surface. J Biol Chem 284:30209-30217 
[29] Bleckmann C, Geyer H, Lieberoth A, Splittstoesser F, Liu Y, Feizi T, Schachner M, Kleene R, 
Reinhold V, Geyer R (2009) O-glycosylation pattern of CD24 from mouse brain. Biol Chem 
390:627-645 
[30] Saghatelyan AK, Gorissen S, Albert M, Hertlein B, Schachner M, Dityatev A (2000) The 
extracellular matrix molecule tenascin-R and its HNK-1 carbohydrate modulate perisomatic 
inhibition and long-term potentiation in the CA1 region of the hippocampus. Eur J Neurosci 
12:3331-3342 
[31] Maeda N, Hamanaka H, Oohira A, Noda M (1995) Purification, characterization and 
developmental expression of a brain-specific chondroitin sulfate proteoglycan, 6B4 
proteoglycan/phosphacan. Neuroscience 67:23-35 
[32] Yagi H, Yanagisawa M, Suzuki Y, Nakatani Y, Ariga T, Kato K, Yu RK (2010) HNK-1 
epitope-carrying tenascin-C spliced variant regulates the proliferation of mouse embryonic 
neural stem cells. J Biol Chem 285:37293-37301 
[33] Kakuda S, Oka S, Kawasaki T (2004) Purification and characterization of two recombinant 
human glucuronyltransferases involved in the biosynthesis of HNK-1 carbohydrate in 
Escherichia coli. Protein Expr Purif 35:111-119 
23 
[34] Terayama K, Oka S, Seiki T, Miki Y, Nakamura A, Kozutsumi Y, Takio K, Kawasaki T (1997) 
Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis 
of the carbohydrate epitope HNK-1. Proc Natl Acad Sci U S A 94:6093-6098 
[35] Terayama K, Seiki T, Nakamura A, Matsumori K, Ohta S, Oka S, Sugita M, Kawasaki T (1998) 
Purification and characterization of a glucuronyltransferase involved in the biosynthesis of the 
HNK-1 epitope on glycoproteins from rat brain. J Biol Chem 273:30295-30300 
[36] Seiki T, Oka S, Terayama K, Imiya K, Kawasaki T (1999) Molecular cloning and expression of 
a second glucuronyltransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. 
Biochem Biophys Res Commun 255:182-187 
[37] Shimoda Y, Tajima Y, Nagase T, Harii K, Osumi N, Sanai Y (1999) Cloning and expression of a 
novel galactoside β1, 3-glucuronyltransferase involved in the biosynthesis of HNK-1 epitope. J 
Biol Chem 274:17115-17122 
[38] Kizuka Y, Matsui T, Takematsu H, Kozutsumi Y, Kawasaki T, Oka S (2006) Physical and 
functional association of glucuronyltransferases and sulfotransferase involved in HNK-1 
biosynthesis. J Biol Chem 281:13644-13651 
[39] Kitagawa H, Tone Y, Tamura J, Neumann KW, Ogawa T, Oka S, Kawasaki T, Sugahara K 
(1998) Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis 
of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem 273:6615-6618 
[40] Tone Y, Kitagawa H, Imiya K, Oka S, Kawasaki T, Sugahara K (1999) Characterization of 
recombinant human glucuronyltransferase I involved in the biosynthesis of the 
glycosaminoglycan-protein linkage region of proteoglycans. FEBS Lett 459:415-420 
[41] Wei G, Bai X, Sarkar AK, Esko JD (1999) Formation of HNK-1 determinants and the 
glycosaminoglycan tetrasaccharide linkage region by UDP-GlcUA:Galactose β1, 
3-glucuronosyltransferases. J Biol Chem 274:7857-7864 
[42] Izumikawa T, Kanagawa N, Watamoto Y, Okada M, Saeki M, Sakano M, Sugahara K, Sugihara 
K, Asano M, Kitagawa H (2010) Impairment of embryonic cell division and glycosaminoglycan 
biosynthesis in glucuronyltransferase-I-deficient mice. J Biol Chem 285:12190-12196 
[43] Bakker H, Friedmann I, Oka S, Kawasaki T, Nifant'ev N, Schachner M, Mantei N (1997) 
Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the 
HNK-1 carbohydrate epitope. J Biol Chem 272:29942-29946 
[44] Ong E, Yeh JC, Ding Y, Hindsgaul O, Fukuda M (1998) Expression cloning of a human 
sulfotransferase that directs the synthesis of the HNK-1 glycan on the neural cell adhesion 
molecule and glycolipids. J Biol Chem 273:5190-5195 
24 
[45] Senn C, Kutsche M, Saghatelyan A, Bosl MR, Lohler J, Bartsch U, Morellini F, Schachner M 
(2002) Mice deficient for the HNK-1 sulfotransferase show alterations in synaptic efficacy and 
spatial learning and memory. Mol Cell Neurosci 20:712-729 
[46] Nakagawa N, Izumikawa T, Kitagawa H, Oka S (2011) Sulfation of glucuronic acid in the 
linkage tetrasaccharide by HNK-1 sulfotransferase is an inhibitory signal for the expression of a 
chondroitin sulfate chain on thrombomodulin. Biochem Biophys Res Commun 415:109-113 
[47] Hashiguchi T, Mizumoto S, Nishimura Y, Tamura J, Yamada S, Sugahara K (2011) Involvement 
of human natural killer-1 (HNK-1) sulfotransferase in the biosynthesis of the 
GlcUA(3-O-sulfate)-Gal-Gal-Xyl tetrasaccharide found in α-thrombomodulin from human urine. 
J Biol Chem 286:33003-33011 
[48] Wakabayashi H, Natsuka S, Mega T, Otsuki N, Isaji M, Naotsuka M, Koyama S, Kanamori T, 
Sakai K, Hase S (1999) Novel proteoglycan linkage tetrasaccharides of human urinary soluble 
thrombomodulin, SO4-3GlcAβ1-3Galβ1-3(±Siaα2-6)Galβ1-4Xyl. J Biol Chem 274:5436-5442 
[49] Aono S, Tokita Y, Shuo T, Yamauchi S, Matsui F, Nakanishi K, Hirano K, Sano M, Oohira A 
(2004) Glycosylation site for chondroitin sulfate on the neural part-time proteoglycan, 
neuroglycan C. J Biol Chem 279:46536-46541 
[50] Nadanaka S, Kitagawa H, Sugahara K (1998) Demonstration of the immature 
glycosaminoglycan tetrasaccharide sequence GlcAβ1-3Galβ1-3Galβ1-4Xyl on recombinant 
soluble human α-thrombomodulin. An oligosaccharide structure on a "part-time" proteoglycan. J 
Biol Chem 273:33728-33734 
[51] Kakuda S, Sato Y, Tonoyama Y, Oka S, Kawasaki T (2005) Different acceptor specificities of 
two glucuronyltransferases involved in the biosynthesis of HNK-1 carbohydrate. Glycobiology 
15:203-210 
[52] Oka S, Terayama K, Imiya K, Yamamoto S, Kondo A, Kato I, Kawasaki T (2000) The N-glycan 
acceptor specificity of a glucuronyltransferase, GlcAT-P, associated with biosynthesis of the 
HNK-1 epitope. Glycoconj J 17:877-885 
[53] Kakuda S, Shiba T, Ishiguro M, Tagawa H, Oka S, Kajihara Y, Kawasaki T, Wakatsuki S, Kato 
R (2004) Structural basis for acceptor substrate recognition of a human glucuronyltransferase, 
GlcAT-P, an enzyme critical in the biosynthesis of the carbohydrate epitope HNK-1. J Biol 
Chem 279:22693-22703 
[54] Shiba T, Kakuda S, Ishiguro M, Morita I, Oka S, Kawasaki T, Wakatsuki S, Kato R (2006) 
Crystal structure of GlcAT-S, a human glucuronyltransferase, involved in the biosynthesis of the 
HNK-1 carbohydrate epitope. Proteins 65:499-508 
25 
[55] Breton C, Bettler E, Joziasse DH, Geremia RA, Imberty A (1998) Sequence-function 
relationships of prokaryotic and eukaryotic galactosyltransferases. J Biochem 123:1000-1009 
[56] Qasba PK, Ramakrishnan B, Boeggeman E (2005) Substrate-induced conformational changes in 
glycosyltransferases. Trends Biochem Sci 30:53-62 
[57] Unligil UM, Zhou S, Yuwaraj S, Sarkar M, Schachter H, Rini JM (2000) X-ray crystal structure 
of rabbit N-acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily. 
EMBO J 19:5269-5280 
[58] Kizuka Y, Nakagawa N, Morita I, Oka S (2012) Requirement of acidic amino acids in the 
Glucuronyltransferase-P (GlcAT-P) flexible loop for its enzymatic activity. In: Mora-Montes 
HM (ed) Glycans: Biochemistry, Characterization and Applications. Nova Publishers, New 
York. 
[59] Yamamoto S, Oka S, Saito-Ohara F, Inazawa J, Kawasaki T (2002) Molecular cloning and 
genomic analysis of mouse glucuronyltransferase involved in biosynthesis of the HNK-1 epitope. 
J Biochem 131:337-347 
[60] Nagase T, Nakamura S, Harii K, Osumi N (2001) Ectopically localized HNK-1 epitope perturbs 
migration of the midbrain neural crest cells in Pax6 mutant rat. Dev Growth Differ 43:683-692 
[61] Dasgupta S, Yanagisawa M, Krishnamurthy K, Liour SS, Yu RK (2007) Tumor necrosis 
factor-α up-regulates glucuronosyltransferase gene expression in human brain endothelial cells 
and promotes T-cell adhesion. J Neurosci Res 85:1086-1094 
[62] Kizuka Y, Kitazume S, Yoshida M, Taniguchi N (2011) Brain-specific expression of 
N-acetylglucosaminyltransferase IX (GnT-IX) is regulated by epigenetic histone modifications. J 
Biol Chem 286:31875-31884 
[63] Kizuka Y, Kobayashi K, Kakuda S, Nakajima Y, Itoh S, Kawasaki N, Oka S (2008) Laminin-1 
is a novel carrier glycoprotein for the nonsulfated HNK-1 epitope in mouse kidney. 
Glycobiology 18:331-338 
[64] Bond JS, Matters GL, Banerjee S, Dusheck RE (2005) Meprin metalloprotease expression and 
regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett 579:3317-3322 
[65] Tauc M, Chatelet F, Verroust P, Vandewalle A, Poujeol P, Ronco P (1988) Characterization of 
monoclonal antibodies specific for rabbit renal brush-border hydrolases: application to 
immunohistological localization. J Histochem Cytochem 36:523-532 
[66] Sasaki T, Fassler R, Hohenester E (2004) Laminin: the crux of basement membrane assembly. J 
Cell Biol 164:959-963 
[67] Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG (2005) The 
26 
β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310:490-493 
[68] Allory Y, Commo F, Boccon-Gibod L, Sibony M, Callard P, Ronco P, Debiec H (2006) Sulfated 
HNK-1 epitope in developing and mature kidney: a new marker for thin ascending loop of Henle 
and tubular injury in acute tubular necrosis. J Histochem Cytochem 54:575-584 
[69] Zhao X, Graves C, Ames SJ, Fisher DE, Spanjaard RA (2009) Mechanism of regulation and 
suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene 
carbohydrate sulfotransferase 10. Cancer Res 69:5218-5225 
[70] Hennet T (2002) The galactosyltransferase family. Cell Mol Life Sci 59:1081-1095 
[71] Lo NW, Shaper JH, Pevsner J, Shaper NL (1998) The expanding β4-galactosyltransferase gene 
family: messages from the databanks. Glycobiology 8:517-526 
[72] Yoshihara T, Sugihara K, Kizuka Y, Oka S, Asano M (2009) Learning/memory impairment and 
reduced expression of the HNK-1 carbohydrate in β4-galactosyltransferase-II-deficient mice. J 
Biol Chem 284:12550-12561 
[73] Kido M, Asano M, Iwakura Y, Ichinose M, Miki K, Furukawa K (1998) Presence of polysialic 
acid and HNK-1 carbohydrate on brain glycoproteins from β-1,4-galactosyltransferase-knockout 
mice. Biochem Biophys Res Commun 245:860-864 
[74] Yano H, Yamamoto-Hino M, Abe M, Kuwahara R, Haraguchi S, Kusaka I, Awano W, 
Kinoshita-Toyoda A, Toyoda H, Goto S (2005) Distinct functional units of the Golgi complex in 
Drosophila cells. Proc Natl Acad Sci U S A 102:13467-13472 
[75] Kizuka Y, Tonoyama Y, Oka S (2009) Distinct transport and intracellular activities of two 
GlcAT-P isoforms. J Biol Chem 284:9247-9256 
[76] Mitsumoto Y, Oka S, Sakuma H, Inazawa J, Kawasaki T (2000) Cloning and chromosomal 
mapping of human glucuronyltransferase involved in biosynthesis of the HNK-1 carbohydrate 
epitope. Genomics 65:166-173 
[77] Giraudo CG, Maccioni HJ (2003) Endoplasmic reticulum export of glycosyltransferases depends 
on interaction of a cytoplasmic dibasic motif with Sar1. Mol Biol Cell 14:3753-3766 
[78] Shaper NL, Charron M, Lo NW, Shaper JH (1998) β1,4-galactosyltransferase and lactose 
biosynthesis: recruitment of a housekeeping gene from the nonmammalian vertebrate gene pool 
for a mammary gland specific function. J Mammary Gland Biol Neoplasia 3:315-324 
[79] Le Douarin NM (2004) The avian embryo as a model to study the development of the neural 
crest: a long and still ongoing story. Mech Dev 121:1089-1102 
[80] Bronner-Fraser M (1987) Perturbation of cranial neural crest migration by the HNK-1 antibody. 
Dev Biol 123:321-331 
27 
[81] Tucker GC, Delarue M, Zada S, Boucaut JC, Thiery JP (1988) Expression of the HNK-1/NC-1 
epitope in early vertebrate neurogenesis. Cell Tissue Res 251:457-465 
[82] Nagase T, Sanai Y, Nakamura S, Asato H, Harii K, Osumi N (2003) Roles of HNK-1 
carbohydrate epitope and its synthetic glucuronyltransferase genes on migration of rat neural 
crest cells. J Anat 203:77-88 
[83] Anzai D, Tonoyama Y, Ikeda A, Kawasaki T, Oka S (2009) Regulated expression of the HNK-1 
carbohydrate is essential for medaka (Oryzias latipes) embryogenesis. Glycobiology 19:868-878 
[84] Yamamoto S, Oka S, Inoue M, Shimuta M, Manabe T, Takahashi H, Miyamoto M, Asano M, 
Sakagami J, Sudo K, Iwakura Y, Ono K, Kawasaki T (2002) Mice deficient in nervous 
system-specific carbohydrate epitope HNK-1 exhibit impaired synaptic plasticity and spatial 
learning. J Biol Chem 277:27227-27231 
[85] Debanne D (1996) Associative synaptic plasticity in hippocampus and visual cortex: cellular 
mechanisms and functional implications. Rev Neurosci 7:29-46 
[86] Isaac JT, Ashby MC, McBain CJ (2007) The role of the GluR2 subunit in AMPA receptor 
function and synaptic plasticity. Neuron 54:859-871 
[87] Saglietti L, Dequidt C, Kamieniarz K, Rousset MC, Valnegri P, Thoumine O, Beretta F, Fagni L, 
Choquet D, Sala C, Sheng M, Passafaro M (2007) Extracellular interactions between GluR2 and 
N-cadherin in spine regulation. Neuron 54:461-477 
[88] Segal M (2005) Dendritic spines and long-term plasticity. Nat Rev Neurosci 6:277-284 
[89] Hering H, Sheng M (2001) Dendritic spines: structure, dynamics and regulation. Nat Rev 
Neurosci 2:880-888 
[90] Morita I, Kakuda S, Takeuchi Y, Kawasaki T, Oka S (2009) HNK-1 (human natural killer-1) 
glyco-epitope is essential for normal spine morphogenesis in developing hippocampal neurons. 
Neuroscience 164:1685-1694 
[91] Saghatelyan AK, Snapyan M, Gorissen S, Meigel I, Mosbacher J, Kaupmann K, Bettler B, 
Kornilov AV, Nifantiev NE, Sakanyan V, Schachner M, Dityatev A (2003) Recognition 
molecule associated carbohydrate inhibits postsynaptic GABA(B) receptors: a mechanism for 
homeostatic regulation of GABA release in perisomatic synapses. Mol Cell Neurosci 24:271-282 
[92] Saghatelyan AK, Dityatev A, Schmidt S, Schuster T, Bartsch U, Schachner M (2001) Reduced 
perisomatic inhibition, increased excitatory transmission, and impaired long-term potentiation in 
mice deficient for the extracellular matrix glycoprotein tenascin-R. Mol Cell Neurosci 
17:226-240 
[93] Bukalo O, Schachner M, Dityatev A (2007) Hippocampal metaplasticity induced by deficiency 
28 
in the extracellular matrix glycoprotein tenascin-R. J Neurosci 27:6019-6028 
[94] Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L (2002) Reactivation of 
ocular dominance plasticity in the adult visual cortex. Science 298:1248-1251 
[95] Gogolla N, Caroni P, Luthi A, Herry C (2009) Perineuronal nets protect fear memories from 
erasure. Science 325:1258-1261 
[96] Weber P, Bartsch U, Rasband MN, Czaniera R, Lang Y, Bluethmann H, Margolis RU, Levinson 
SR, Shrager P, Montag D, Schachner M (1999) Mice deficient for tenascin-R display alterations 
of the extracellular matrix and decreased axonal conduction velocities in the CNS. J Neurosci 
19:4245-4262 
[97] Dino MR, Harroch S, Hockfield S, Matthews RT (2006) Monoclonal antibody Cat-315 detects a 
glycoform of receptor protein tyrosine phosphatase beta/phosphacan early in CNS development 
that localizes to extrasynaptic sites prior to synapse formation. Neuroscience 142:1055-1069 
[98] Tang NE, Luyten GP, Mooy CM, Naus NC, de Jong PT, Luider TM (1996) HNK-1 antigens on 
uveal and cutaneous melanoma cell lines. Melanoma Res 6:411-418 
[99] Thies A, Schachner M, Berger J, Moll I, Schulze HJ, Brunner G, Schumacher U (2004) The 
developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in 
cutaneous malignant melanoma. J Pathol 203:933-939 
[100] Suzuki-Anekoji M, Suzuki M, Kobayashi T, Sato Y, Nakayama J, Suzuki A, Bao X, Angata K, 
Fukuda M (2011) HNK-1 glycan functions as a tumor suppressor for astrocytic tumor. J Biol 
Chem 286:32824-32833 
[101] Ilyas AA, Quarles RH, MacIntosh TD, Dobersen MJ, Trapp BD, Dalakas MC, Brady RO (1984) 
IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in 
the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci U S A 
81:1225-1229 
[102] Ariga T, Kohriyama T, Freddo L, Latov N, Saito M, Kon K, Ando S, Suzuki M, Hemling ME, 
Rinehart KL, Jr., et al. (1987) Characterization of sulfated glucuronic acid containing glycolipids 
reacting with IgM M-proteins in patients with neuropathy. J Biol Chem 262:848-853 
[103] Hays AP, Latov N, Takatsu M, Sherman WH (1987) Experimental demyelination of nerve 
induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 
37:242-256 
[104] Maeda Y, Brosnan CF, Miyatani N, Yu RK (1991) Preliminary studies on sensitization of Lewis 
rats with sulfated glucuronyl paragloboside. Brain Res 541:257-264 
[105] Jeffries AR, Mungall AJ, Dawson E, Halls K, Langford CF, Murray RM, Dunham I, Powell JF 
29 
(2003) β-1,3-Glucuronyltransferase-1 gene implicated as a candidate for a schizophrenia-like 
psychosis through molecular analysis of a balanced translocation. Mol Psychiatry 8:654-663 
[106] Kahler AK, Djurovic S, Rimol LM, Brown AA, Athanasiu L, Jonsson EG, Hansen T, 
Gustafsson O, Hall H, Giegling I, Muglia P, Cichon S, Rietschel M, Pietilainen OP, Peltonen L, 
Bramon E, Collier D, St Clair D, Sigurdsson E, Petursson H, Rujescu D, Melle I, Werge T, 
Steen VM, Dale AM, Matthews RT, Agartz I, Andreassen OA (2011) Candidate gene analysis of 
the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: 
B3GAT2 is associated with disease risk and cortical surface area. Biol Psychiatry 69:90-96 
[107] Thomas SN, Soreghan BA, Nistor M, Sarsoza F, Head E, Yang AJ (2005) Reduced neuronal 
expression of synaptic transmission modulator HNK-1/neural cell adhesion molecule as a 
potential consequence of amyloid β-mediated oxidative stress: a proteomic approach. J 
Neurochem 92:705-717 
[108] Simon-Haldi M, Mantei N, Franke J, Voshol H, Schachner M (2002) Identification of a peptide 
mimic of the L2/HNK-1 carbohydrate epitope. J Neurochem 83:1380-1388 
[109] Bhunia A, Vivekanandan S, Eckert T, Burg-Roderfeld M, Wechselberger R, Romanuka J, 
Bachle D, Kornilov AV, von der Lieth CW, Jimenez-Barbero J, Nifantiev NE, Schachner M, 
Sewald N, Lutteke T, Hans-Joachim G, Siebert HC (2010) Why structurally different cyclic 
peptides can be glycomimetics of the HNK-1 carbohydrate antigen. J Am Chem Soc 132:96-105 
[110] Irintchev A, Wu MM, Lee HJ, Zhu H, Feng YP, Liu YS, Bernreuther C, Loers G, You SW, 
Schachner M (2011) Glycomimetic improves recovery after femoral injury in a non-human 
primate. J Neurotrauma 28:1295-1306 
[111] Simova O, Irintchev A, Mehanna A, Liu J, Dihne M, Bachle D, Sewald N, Loers G, Schachner 





β1	 β1	3	3	 4	HSO3	 β1	
GlcAT-P(S) HNK-1ST β4GalT2 
HNK-1	
GlcAT-I 
β1	 β1	3	3	 3	HSO3	 β1	 4	 β1	
HNK-1ST 
Linkage tetrasaccharide	
Heparan sulfate, chondroitin sulfate	
β1	 β1	3	 3	 β1	 4	 β1	











Fig. 1  Structure of HNK-1 epitope and biosynthetic enzymes. (A) 
Structure of HNK-1 and the enzymes that biosynthesize it. (B) Structure 
of the proteoglycan linkage tetrasaccharide. Sulfation of this glycan by 
HNK-1ST may be an off-switch for further biosynthesis of 
glycosaminoglycan.	
Short GlcAT-P	 Long GlcAT-P	














13 amino acids 
TM	
 stem	 catalytic domain	Long GlcAT-P 
Short GlcAT-P 






 stem	 catalytic domain	
Fig. 2  Regulation of HNK-1 expression in cells. (A) Complex of HNK-1-related enzymes 
comprising β4GalT2, GlcAT-P(S) and HNK-1ST. This specialized complex may work for efficient 
biosynthesis of HNK-1 carbohydrate. (B) Two GlcAT-P isoforms. The longer isoform has an 
additional 13 amino acids in its cytosolic tail. A dibasic motif exists in the cytosolic tail in both 
isoforms. (C) Distinct ER exiting processes for two GlcAT-P isoforms. The short isoform can be 
easily bound by Sar1 to be conveyed from the ER to Golgi, which results in higher intracellular 
activity in the Golgi. In the case of the long form, the additional 13 amino acids weaken the 























GluA2: AMPA receptor containing GluA2	
Fig. 3  HNK-1 on GluA2 regulates its synaptic membrane residency and 
spine maturation process. (A) A glutamate receptor subunit, GluA2, 
interacts with N-cadherin at the postsynaptic membrane. In GlcAT-P 
knockout neurons, loss of HNK-1 on GluA2 results in weaker interaction 
with N-cadherin and enhanced internalization of GluA2. This 
phenomenon could be one mechanism behind the reduced long-term 
potentiation in GlcAT-P knockout neurons. (B) In GlcAT-P knockout 
neurons, immature thin spines are observed. Also, loss of HNK-1 on 
GluA2 changes its localization from spines to dendritic shafts.	
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Fig. 4  HNK-1 expression at perineuronal 
nets (PNs) in GlcAT-P knockout brain. (A) 
Mouse brain cortex was immunostained with 
a HNK-1 mAb. HNK-1 expression was 
markedly reduced in the knockout mice but 
still detected in PNs. (B) Magnified images 
of HNK-1 expression at PNs in cultured 
GlcAT-P knockout neurons. PNs were stained 
with Wisteria Floribunda lectin.	
	
